Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2666-5247(21)00356-6
PubMed Identifier: 35544095
Publication URI: http://europepmc.org/abstract/MED/35544095
Type: Journal Article/Review
Volume: 3
Parent Publication: The Lancet. Microbe
Issue: 5
ISSN: 2666-5247